Cellular Immunotherapy for Cancer Meeting Materials
The Cellular Immunotherapy for Cancer Working Committee provides scientific oversight for studies related to the utilization and outcomes after CAR-T cell therapies and other cellular immunotherapies. Studies that focus on specific outcomes, a predictor of outcomes, and utilization of CAR-T cells should be submitted to this committee.
Meetings are held annually during the Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR. Anyone with interest or expertise in the focus area is encouraged to attend.
2023
- 2023 Cellular Immunotherapy for Cancer Agenda
- 2023 Cellular Immunotherapy for Cancer Minutes and 2023-2024 Overview Plan
2022
- 2022 Cellular Immunotherapy for Cancer Agenda
- 2022 Cellular Immunotherapy for Cancer Minutes and 2022-2023 Overview Plan
2021
- 2021 Cellular Immunotherapy for Cancer Status Report
- 2021 Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR Combined WC Session Minutes
2020
- 2020 Cellular Immunotherapy for Cancer Agenda
- 2020 Cellular Immunotherapy for Cancer Minutes and 2020-2021 Overview Plan
2019
- 2019 Autoimmune Diseases and Cellular Therapies Agenda
- 2019 Autoimmune Diseases and Cellular Therapies Minutes and 2019-2020 Overview Plan
The TCT® Trademark belongs to the Cardiovascular Research Foundation. ASTCT, CIBMTR, MCW, NMDP, the 2019, 2020, and 2021 TCT Conferences and materials are NOT affiliated with or sponsored by Cardiovascular Research Foundation.